![Peter T. Lansbury](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Peter T. Lansbury
Corporate Officer/Principal bij Harvard Medical School
Profiel
Peter T.
Lansbury is the founder of Link Medicine Corp.
He is currently a Professor at Harvard Medical School.
Previously, he held positions as Director at Morris K.
Udall & Stewart L.
Udall Foundation, Professor at The Brigham & Women's Hospital, Inc., and Associate Professor at Massachusetts Institute of Technology.
He also served as Chief Scientific Officer at Lysosomal Therapeutics, Inc. Lansbury received his doctorate from Harvard University in 1985 and his undergraduate degree from Princeton University in 1980.
Actieve functies van Peter T. Lansbury
Bedrijven | Functie | Begin |
---|---|---|
Harvard Medical School | Corporate Officer/Principal | - |
Eerdere bekende functies van Peter T. Lansbury
Bedrijven | Functie | Einde |
---|---|---|
Lysosomal Therapeutics, Inc.
![]() Lysosomal Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Lysosomal Therapeutics, Inc. engages in the innovation, research, and development in the field of neurodegeneration. It focuses in lysosomal biology in developing novel small molecules for use in the treatment of neurodegenerative diseases. The company was founded by Dimitri Krainc, Joseph Mazzulli, Henri A. Termeer, Robert J. Carpenter, Peter Wirth, Edmund J. Sybertz, and Kees Cornelis Been in 2011 and is headquartered in Cambridge, MA. | Hoofd Techniek/Wetenschap/O&O | - |
Morris K. Udall & Stewart L. Udall Foundation | Directeur/Bestuurslid | - |
Massachusetts Institute of Technology | Corporate Officer/Principal | - |
The Brigham & Women's Hospital, Inc.
![]() The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services The Brigham & Women's Hospital, Inc. provides health care services. The firm offers treatment for cancer, cardio vascular, neurosciences, orthopedic, arthritis, women's health and clinical services. The company was founded in 1980 and is headquartered in Boston, MA. | Corporate Officer/Principal | - |
Link Medicine Corp.
![]() Link Medicine Corp. Pharmaceuticals: MajorHealth Technology Link Medicine Corp. develops disease modifying neurodegenerative therapies. The company was founded by Edward I. Rudman, Peter T. Lansbury, David Neafus and Adam J. Rosenberg in 2005 and is headquartered in Cambridge, MA. | Oprichter | - |
Opleiding van Peter T. Lansbury
Harvard University | Doctorate Degree |
Princeton University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 4 |
---|---|
Link Medicine Corp.
![]() Link Medicine Corp. Pharmaceuticals: MajorHealth Technology Link Medicine Corp. develops disease modifying neurodegenerative therapies. The company was founded by Edward I. Rudman, Peter T. Lansbury, David Neafus and Adam J. Rosenberg in 2005 and is headquartered in Cambridge, MA. | Health Technology |
The Brigham & Women's Hospital, Inc.
![]() The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services The Brigham & Women's Hospital, Inc. provides health care services. The firm offers treatment for cancer, cardio vascular, neurosciences, orthopedic, arthritis, women's health and clinical services. The company was founded in 1980 and is headquartered in Boston, MA. | Health Services |
Morris K. Udall & Stewart L. Udall Foundation | |
Lysosomal Therapeutics, Inc.
![]() Lysosomal Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Lysosomal Therapeutics, Inc. engages in the innovation, research, and development in the field of neurodegeneration. It focuses in lysosomal biology in developing novel small molecules for use in the treatment of neurodegenerative diseases. The company was founded by Dimitri Krainc, Joseph Mazzulli, Henri A. Termeer, Robert J. Carpenter, Peter Wirth, Edmund J. Sybertz, and Kees Cornelis Been in 2011 and is headquartered in Cambridge, MA. | Health Technology |